Outcome of Surgical Treatment for Borrmann Type 4 Gastric Cancer.
10.5230/jkgca.2003.3.4.221
- Author:
Sung Soo PARK
1
;
Sung Hoon KIM
;
Seung Joo KIM
;
Chong Suk KIM
;
Young Jae MOK
Author Information
1. Department of Surgery, Korea University College of Medicine, Seoul, Korea. yjmok@mail.korea.ac.kr
- Publication Type:Original Article
- Keywords:
Gastric cancer;
Borrmann type 4;
Prognosis
- MeSH:
Gastrectomy;
Humans;
Korea;
Lymph Nodes;
Neoplasm Metastasis;
Prognosis;
Retrospective Studies;
Stomach;
Stomach Neoplasms*;
Survival Rate
- From:Journal of the Korean Gastric Cancer Association
2003;3(4):221-225
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The prognosis for Borrmann type 4 gastric cancer is dismal although therapies for gastric cancer have been developed. We investigated the outcomes for Borrmann type 4 gastric cancers compared to those for other types of cancer. MATENRIALS AND METHODS: Between 1993 and 2000, 777 patients with advanced gastric cancer underwent surgical resection at the Department of Surgery, Korea University Hospital. The clinicopathologic features of 138 patients with Borrmann type 4 carcinomas of the stomach were retrospectively reviewed from the database of gastric cancer. The results were compared with those of 639 patients with other types of gastric carcinomas. RESULTS: Patients with Borrmann type 4 carcinomas tended to be younger and to have larger tumors. The location, the depth of invasion, lymph node metastasis, and distant metastasis were significantly different between the two groups. Patients with Borrmann type 4 carcinomas had a more advanced stage than patients with other types of carcinomas. The analysis of the treatment factors revealed that total gastrectomies were more frequent in the group with Borrmann type 4 carcinomas and that the curative resection rate of patients with Borrmann type 4 gastric carcinomas was lower than that of patients with other types of gastric carcinomas (P<0.001). The 5-year survival rate for Borrmann type 4 gastric cancer was 19.4% and that for other types was 52.9% (P=0.001). In curative cases, the 5-year survival rates were 32.8% for patients with Borrmann type 4 gastric carcinomas and 63.4% for other types of carcinomas (P=0.001). CONCLUSION: Borrmann type IV gastric cancer has more advanced features and a poorer prognosis than other types of gastric cancer. Improving the prognosis for patients with Borrmann type 4 gastric cancer requires early detection and a curative resection.
